Patents
US 10413572 B2: Liquid amnion transplant product
- Granted
- 2019-09-17
- Filed
- 2015-08-11 application 14823770
- Type
- Utility · 2 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of −65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.
Source: PVGPATDIS, file of 2026-04-10 (ipg190917.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Vivex Biomedical, Inc. 42 patents | US company or organization | Atlanta, GA | Vivex Biomedical, Inc. Form D issuer EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Shabnam Namin | Miami, FL | 19 | PVGPATDIS, file of 2026-04-10 | |
| Gaëtan Jean-Robert Delcroix | Miami, FL | 14 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K35/50 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2022-08-29 | Release of security interest Release of security interest | BANKUNITED, N.A. signed 2022-08-25 | VIVEX BIOLOGICS GROUP, INC. ATLANTA, GA | 61333/853 | PASDL, file of 2026-10-15 |
| 2022-08-04 | Security interest Security interest Security interest | VIVEX BIOLOGICS GROUP, INC. signed 2022-07-31 | HERITAGE BANK OF COMMERCE SAN JOSE, CA | 61084/607 | PASDL, file of 2026-10-15 |
| 2019-12-12 | Release of security interest Release of security interest | HERITAGE BANK OF COMMERCE signed 2019-12-11 | VIVEX BIOMEDICAL, INC. ATLANTA, GA UMTB BIOMEDICAL, INC ATLANTA, GA ADVANCED NUMED TECHNOLOGIES, LTD. ATLANTA, GA VIVEX BIOMEDICAL INTERNATIONAL, INC. ATLANTA, GA | 51282/653 | PASDL, file of 2026-10-15 |
| 2019-12-11 | Security interest Security interest Notice of grant of security interest in patents | VIVEX BIOLOGICS GROUP, INC. signed 2019-12-10 | BANKUNITED, N.A. MIAMI, FL | 51260/64 | PASDL, file of 2026-10-15 |
| 2019-08-16 | Name change Change of name | VIVEX BIOLOGICS, INC. signed 2019-07-31 | VIVEX BIOLOGICS GROUP, INC. ATLANTA, GA | 50079/225 | PASDL, file of 2026-10-15 |
| 2019-08-16 | Name change Change of name | VIVEX BIOMEDICAL, INC. signed 2019-07-01 | VIVEX BIOLOGICS, INC. ATLANTA, GA | 50079/179 | PASDL, file of 2026-10-15 |
| 2017-02-22 | Security interest Security interest Security interest | VIVEX BIOMEDICAL, INC. signed 2017-02-21 UMTB BIOMEDICAL, INC. signed 2017-02-21 ADVANCED NUMED TECHNOLOGIES, LTD. signed 2017-02-21 VIVEX BIOMEDICAL INTERNATIONAL, INC. signed 2017-02-21 | HERITAGE BANK OF COMMERCE SAN JOSE, CA | 41782/452 | PASDL, file of 2026-10-15 |
| 2017-02-06 | Assignment Assignment of assignor's interest | NAMIN, SHABNAM signed 2015-08-11 DELCROIX, GAETAN JEAN-ROBERT signed 2015-08-13 | VIVEX BIOMEDICAL, INC. MARIETTA, GA | 41184/976 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.